Switch to
More onapp

Vivimed Labs Ltd

VIVIMEDLAB
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹89 cr, stock is ranked 2,249
High RiskStock is 3.22x as volatile as Nifty
10.250.50 (-4.65%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹89 cr, stock is ranked 2,249
High RiskStock is 3.22x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
-1.32
PB RatioPB Ratio
0.11
Dividend YieldDiv. Yield
Sector PESector PE
13.38
Sector PBSector PB
2.63
Sector Div YldSctr Div Yld
2.30%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vivimed Labs Limited makes active ingredients for a range of home, personal care and industrial products and is engaged in contractual manufacturing for active pharmaceutical ingredient and contract manufacturing of formulations for generic companies

Financial TrendFinancial statements 

20192020202120221.341.070.870.240.06-0.11-0.08-0.07
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 7.61%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnAug 12, 2022

Vivimed Labs Limited has informed the Exchange about Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022 | Download

Vivimed Labs Limited has informed the Exchange about Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022 | Download

Cash Dividend 
Ex. DateSep 19, 2018

Final • Div/Share: ₹ 0.4

Cash Dividend 
Ex. DateSep 21, 2017

Final • Div/Share: ₹ 0.4

See all events